McArdle and colleagues examined the abundance of NK cells, MDSCs, monocyte subsets and Foxp3+ Tregs in the peripheral blood of 85 breast cancer patients and they found that chemotherapy had no effect on the percentage of these immune cells, but peripheral blood cells could distinguish TNBC patients that are at high risk of relapse after chemotherapy [86]. Here, FOXP3 is linked to breast carcinoma.